Guardant Health
GH
#1579
Rank
S$17.00 B
Marketcap
S$130.93
Share price
-1.21%
Change (1 day)
174.76%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -S$0.53 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$0.90 Billion. In 2024 the company made an earning of -S$0.57 Billion, an increase over its 2023 earnings that were of -S$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.53 Billion-6.8%
2024 -S$0.57 Billion-9.12%
2023 -S$0.62 Billion-26.73%
2022 -S$0.85 Billion69.96%
2021 -S$0.5 Billion56.35%
2020 -S$0.32 Billion252.69%
2019 -S$90.05 Million-17.22%
2018 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-S$0.41 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-S$1.39 Billion 170.04%๐Ÿ‡บ๐Ÿ‡ธ USA